Spike protein of SARS-CoV-2 — Drug Target

All drugs that target Spike protein of SARS-CoV-2 — marketed and clinical-stage. Includes 2 drug classes acting on this target.

Drug classes

mRNA vaccine · Monoclonal antibody

Marketed (3)

• BNT162b5 Bivalent (Original/OMI BA.4/BA.5) · Pfizer · mRNA vaccine · Infectious Disease
  Targets the SARS-CoV-2 virus to prevent and treat COVID-19
• Part A: ATM-AVI Single Dose, Cohorts 1-4 · Pfizer · Monoclonal antibody · Infectious Disease
• BNT162b2 (Omi KP.2) · Pfizer Inc. · mRNA vaccine · Immunology